Cell-Based Therapies for Multiple Sclerosis May Eliminate Need for Other Treatments
About 2.5 million people around the world and 400,000 Americans are affected by multiple sclerosis (MS), a disabling disease of the nervous system in which the body’s immune system attacks the protective myelin sheath that covers nerves. This leads to gaps in communication between the brain and various parts of the body. In advanced cases, [Read More]